Infrared Imaging Combined with Machine Learning for Detection of the (Pre)Invasive Pancreatic Neoplasia

IF 4.9 Q1 CHEMISTRY, MEDICINAL
Danuta Liberda-Matyja, Kinga B. Stopa, Daria Krzysztofik, Pawel E. Ferdek*, Monika A. Jakubowska* and Tomasz P. Wrobel*, 
{"title":"Infrared Imaging Combined with Machine Learning for Detection of the (Pre)Invasive Pancreatic Neoplasia","authors":"Danuta Liberda-Matyja,&nbsp;Kinga B. Stopa,&nbsp;Daria Krzysztofik,&nbsp;Pawel E. Ferdek*,&nbsp;Monika A. Jakubowska* and Tomasz P. Wrobel*,&nbsp;","doi":"10.1021/acsptsci.4c0068910.1021/acsptsci.4c00689","DOIUrl":null,"url":null,"abstract":"<p >With the challenge of limited early stage detection and a resulting five-year survival rate of only 13%, pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers. Replacing the high-cost and time-consuming grading of pancreatic samples by pathologists with automated diagnostic approaches can revolutionize PDAC detection and thus accelerate patient admission into the clinical setting for treatment. To address this unmet diagnostic need and facilitate the shift of tissue screening toward automated systems, we combined stain-free histology─specifically, Fourier-transform infrared (FT-IR) imaging─with machine learning. The obtained stain-free model was trained to distinguish between normal, benign, and malignant areas in analyzed specimens using hematoxylin and eosin stained pancreatic tissues isolated from KC (Kras<sup>G12D/+</sup>; Pdx1-Cre) or KPC mice (Kras<sup>G12D/+</sup>; Trp53<sup>R172H/+</sup>; Pdx1-Cre). Due to the pancreas-specific mosaic expression of the mutant <i>Kras</i> and <i>Trp53</i> genes, changes in pancreatic tissues of this mouse model of PDAC closely mirror the gradual transformation of normal pancreatic epithelia into (pre)malignant structures. Thus, this mouse model provides a reliable representation of human disease progression, which we tracked in our study with a Random Forest classifier to achieve accurate detection at the cellular level. This approach yielded a comprehensive model that distinguishes normal pancreatic tissues from pathological features such as pancreatic intraepithelial neoplasia (PanIN), cancerous regions, hemorrhages, and collagen fibers, as well as a streamlined model designed to rapidly identify normal tissues versus pathologically altered regions, including PanINs. These models offer highly accurate diagnostic tools for the early detection of pancreatic malignancies, thus significantly improving the chance for timely therapeutic intervention against PDAC.</p>","PeriodicalId":36426,"journal":{"name":"ACS Pharmacology and Translational Science","volume":"8 4","pages":"1096–1105 1096–1105"},"PeriodicalIF":4.9000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/epdf/10.1021/acsptsci.4c00689","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Pharmacology and Translational Science","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsptsci.4c00689","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

With the challenge of limited early stage detection and a resulting five-year survival rate of only 13%, pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers. Replacing the high-cost and time-consuming grading of pancreatic samples by pathologists with automated diagnostic approaches can revolutionize PDAC detection and thus accelerate patient admission into the clinical setting for treatment. To address this unmet diagnostic need and facilitate the shift of tissue screening toward automated systems, we combined stain-free histology─specifically, Fourier-transform infrared (FT-IR) imaging─with machine learning. The obtained stain-free model was trained to distinguish between normal, benign, and malignant areas in analyzed specimens using hematoxylin and eosin stained pancreatic tissues isolated from KC (KrasG12D/+; Pdx1-Cre) or KPC mice (KrasG12D/+; Trp53R172H/+; Pdx1-Cre). Due to the pancreas-specific mosaic expression of the mutant Kras and Trp53 genes, changes in pancreatic tissues of this mouse model of PDAC closely mirror the gradual transformation of normal pancreatic epithelia into (pre)malignant structures. Thus, this mouse model provides a reliable representation of human disease progression, which we tracked in our study with a Random Forest classifier to achieve accurate detection at the cellular level. This approach yielded a comprehensive model that distinguishes normal pancreatic tissues from pathological features such as pancreatic intraepithelial neoplasia (PanIN), cancerous regions, hemorrhages, and collagen fibers, as well as a streamlined model designed to rapidly identify normal tissues versus pathologically altered regions, including PanINs. These models offer highly accurate diagnostic tools for the early detection of pancreatic malignancies, thus significantly improving the chance for timely therapeutic intervention against PDAC.

红外成像结合机器学习检测胰腺浸润性肿瘤
胰腺导管腺癌(pancreatic ductal adencarcinoma, PDAC)是最致命的癌症之一,由于早期检测有限,其5年生存率仅为13%。用自动化诊断方法取代病理学家对胰腺样本进行高成本和耗时的分级,可以彻底改变PDAC的检测,从而加快患者进入临床治疗的速度。为了解决这一未满足的诊断需求,并促进组织筛查向自动化系统的转变,我们将无染色组织学(特别是傅里叶变换红外(FT-IR)成像)与机器学习相结合。利用苏木精和伊红染色的KC (KrasG12D/+;Pdx1-Cre)或KPC小鼠(KrasG12D/+;Trp53R172H / +;Pdx1-Cre)。由于Kras和Trp53突变基因的胰腺特异性嵌合表达,该PDAC小鼠模型胰腺组织的变化密切反映了正常胰腺上皮向(前)恶性结构的逐渐转变。因此,该小鼠模型提供了人类疾病进展的可靠表示,我们在研究中使用随机森林分类器进行跟踪,以在细胞水平上实现准确检测。该方法产生了一个综合模型,可以区分正常胰腺组织与病理特征,如胰腺上皮内瘤变(PanIN)、癌变区域、出血和胶原纤维,以及一个流线型模型,旨在快速识别正常组织与病理改变区域,包括PanINs。这些模型为胰腺恶性肿瘤的早期发现提供了高度准确的诊断工具,从而显著提高了对PDAC进行及时治疗干预的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Pharmacology and Translational Science
ACS Pharmacology and Translational Science Medicine-Pharmacology (medical)
CiteScore
10.00
自引率
3.30%
发文量
133
期刊介绍: ACS Pharmacology & Translational Science publishes high quality, innovative, and impactful research across the broad spectrum of biological sciences, covering basic and molecular sciences through to translational preclinical studies. Clinical studies that address novel mechanisms of action, and methodological papers that provide innovation, and advance translation, will also be considered. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest to the journal. Nonetheless, all innovative and impactful research that has an articulated translational relevance will be considered. ACS Pharmacology & Translational Science does not publish research on biological extracts that have unknown concentration or unknown chemical composition. Authors are encouraged to use the pre-submission inquiry mechanism to ensure relevance and appropriateness of research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信